Previous slide
Next slide
연구분야 안내
연구실 주요 연구분야 입니다.
서울대학교 분자병리학 연구실에 오신 것을 환영합니다.
본 연구실은 암 발생 메커니즘에 대한 포괄적 이해, 암 표적 유전자의 발굴 및 검증, 분자생물학적 이해를 바탕으로 한 바이오마커 발굴과 항체 기반 신약개발을 목표로 연구하고 있습니다.
주요 연구 분야로는 Biomarker discovery, Antibody based therapeutics, Cell based therapy 등이 있습니다.
교수진
최근 논문
Peripheral immune profiling identifies CD8⁺ TEMRA and CD4⁺ T TIGIT⁺ cells as independent prognostic markers for first-line immune checkpoint inhibitors in advanced non-small cell lung cancer.
Jieun Park, Juwhan Choi, Seunghun Lee, Chae Rin Kim, Yeonwoo Lee, Jihyun Park, Yulim Lee, Young Kee Shin & Sung Yong Lee.
2026
Respiratory Research
An Ant-Inspired Dielectric Elastomer Soft Robot With Unequal Biaxial Pre-Stretching for Fast Locomotion and Versatile Applications.
He Yu, Changyunkun Xiao, Tianyi Duan, Yuqing Yang, Youngkee Shin, Kunpeng Li, Eunseong Kim, Namyoung Kim, Yang Li.
2026
Advanced Functional Materials
Molecular basis for a pore block of Tentonin 3 expressed in HEK293 cells by a conopeptide, NMB-1
Sujin Lim, Junhyuk Woo, Sungmin Pak, Joonho Paik, Gyu-Sang Hong, Ji Hun Wi, Sanghee Lee, Cristina Fenollar-Ferrer, Kyungreem Han, Young Kee Shin, Uhtaek Oh
2026
British Journal of Pharmacology
Prognostic impact of sarcopenia and blood biomarkers in advanced non-small cell lung cancer on first-line immune checkpoint inhibitors
Jieun Park, Juwhan Choi, Seunghun Lee, Jihyun Park , Chae Rinim, Yeonwoo Lee, Yulim Lee, Young Kee Shin & Sung Yong Lee.
2026
Scientific Reports
공지사항
-
2026-03-10
-
2026-03-10
-
2025-09-11
-
2025-09-11
-
2025-06-13
-
2025-04-03
-
2025-01-31